Sionna Therapeutics Q2 EPS $(0.66) Misses $(0.65) Estimate
Sionna Therapeutics (NASDAQ:SION) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.65) by 1.54 percent. This is a 60.98 percent decrease over losses of $(0.41) per share
Sionna Therapeutics lost more money per share than experts predicted, and its losses got much bigger compared to last year. When a company's losses grow like this, it's worth noticing whether they're spending money on important projects or if something went wrong.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.